Andre Briosa E Gala
Overview
Explore the profile of Andre Briosa E Gala including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
61
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sharp A, Pope M, Briosa E Gala A, Varini R, Banerjee A, Betts T
Europace
. 2025 Mar;
PMID: 40071310
Background And Aims: Advanced technologies such as charge density mapping (CDM) show promise in guiding adjuvant ablation in patients with persistent atrial fibrillation (AF); however, their limited availability restricts widespread...
2.
Sharp A, Pope M, Briosa E Gala A, Varini R, Betts T, Banerjee A
R Soc Open Sci
. 2025 Jan;
12(1):241048.
PMID: 39816746
Atrial fibrillation (AF) is the most prevalent clinical arrhythmia, posing significant mortality and morbidity challenges. Outcomes of current catheter ablation treatment strategies are suboptimal, highlighting the need for innovative approaches....
3.
Briosa E Gala A, Pope M, Leo M, Sharp A, Banerjee A, Field D, et al.
J Arrhythm
. 2024 Oct;
40(5):1093-1101.
PMID: 39416234
Introduction: The novel Confirm Rx™ implantable cardiac monitor (ICM) with SharpSense™ technology incorporates a new P-wave discriminator designed to improve AF detection. This study aimed to evaluate the diagnostic performance...
4.
Leo M, Banerjee A, Briosa E Gala A, Pope M, Pedersen M, Rajappan K, et al.
Pacing Clin Electrophysiol
. 2024 Aug;
47(10):1404-1411.
PMID: 39107948
Background: When using lesion size index (LSI) to guide catheter ablation, it is unclear what combination of power, contact force and time would be preferable to use and what LSI...
5.
Briosa E Gala A, Pope M, Leo M, Sharp A, Tsoi V, Paisey J, et al.
Arrhythm Electrophysiol Rev
. 2023 Aug;
12:e05.
PMID: 37600156
Aims: In patients with a low AF burden and long periods of sinus rhythm, 'pill-in-the-pocket' oral anticoagulation (OAC) may, taken as needed in response to AF episodes, offer the same...
6.
Briosa E Gala A, Curzen N
Heart Int
. 2022 Oct;
14(1):13-15.
PMID: 36277662
The ISCHEMIA trial (International study of comparative health effectiveness with medical and invasive approaches; ClinicalTrials.gov Identifier: NCT01471522) has informed practice in patients with stable angina and confirms what other less...
7.
Leo M, Sharp A, Briosa E Gala A, Pope M, Betts T
J Interv Card Electrophysiol
. 2022 Jul;
PMID: 35835888
The implantable cardioverter-defibrillator (ICD) is a proven treatment for preventing sudden cardiac death. Transvenous leads are associated with significant mortality and morbidity, and the subcutaneous ICD (S-ICD) addresses this. However,...
8.
Pope M, Kuklik P, Briosa E Gala A, Leo M, Mahmoudi M, Paisey J, et al.
J Am Heart Assoc
. 2022 May;
11(11):e021166.
PMID: 35621197
Background Adenosine shortens action potential duration and refractoriness and provokes atrial fibrillation. This study aimed to evaluate the effect of adenosine on mechanisms of wavefront propagation during atrial fibrillation. Methods...
9.
Briosa E Gala A, Pope M, Leo M, Lobban T, Betts T
Clin Med (Lond)
. 2022 Jan;
22(1):77-82.
PMID: 35078798
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and a growing public health epidemic. In the UK, over 1.3 million people have a diagnosis of AF and an...
10.
Briosa E Gala A, Pope M, Leo M, Kelion A, Bashir Y
Rev Port Cardiol (Engl Ed)
. 2021 Dec;
40(12):991.
PMID: 34922711
No abstract available.